With all of the lung cancer updates this year, be sure to join us in downtown Washington, DC on Saturday, October 19th, 2024 for #DCLung24 for a one-day #CME with all the latest data presented by world class experts! Agenda and registration below:

medstarhealth.org/dclung24

Join us today at 6 pm EDT to discuss lung cancer in young individuals (<50 years)

Ana amazing collaboration between #FlorezLab and Young Lung Cancer Initiative

Poster presentation on reconsideration of #IO in the inpatient setting at MedStar Georgetown for the MedStar Health Georgetown University #Research & #Education Symposium. IP IO may not be appropriate. #MedEd Georgetown Lombardi Georgetown UniversityHOF #MedTwitter

Dr. Andrew Tiu presents MPN symptom burden and outcomes among US Veterans Affairs! #meded #medtwitter MedStar Georgetown MPN_Hub Georgetown Lombardi Georgetown Hematology/Oncology Fellowship

The MedStar Health MedStar Georgetown #Research & #Education Symposium is underway! #MedEd Georgetown Lombardi Georgetown Hematology/Oncology Fellowship #MedTwitter

Join us for the webinar on “Clinical Trials for Thymic Tumors,” on May 24th, 2024 at 9:30 am EDT, moderated by Chul Kim! Register at itmig.org/event/clinical…
#ITMIG #thymoma #thymiccarcinoma #TET Hem-Onc Fellows Network ASCO NCICancerTrials Gilead Sciences #ADCs #lcsm

Enjoying #Miami with this ray of sunshine,🕶️☀️ Narjust Florez, MD, FASCO 🕶️☀️at the PrecisCa fellows forum! Meeting many bright minds🧠and current and future leaders in #oncology ! Hem-Onc Fellows Network #lcsm

On April 26, 2024, the FDA issued 3 draft guidance documents on eligibility criteria in cancer clinical trials to address:
📝 performance status
⌛ washout periods
💊 📊 concomitant medications and laboratory values
fda.gov/regulatory-inf… search 'eligibility'

Thank you Dr. Gustavo Rivera and OncLive.com for hosting a wonderful discussion on AML! And even better to see colleagues Hetty Carraway Lacey Williams Samah Nassereddine MD Aarthi Shenoy at my old stomping ground MedStar Georgetown

Why hello, #Miami ! ☀️🕶️☀️PrecisCa Hem-Onc Fellows Network #lcsm

#NIH is revising the application & peer review process for fellowship grants. We want to make sure promising scientists aren’t left behind. Learn more about the changes taking effect after 1/25/25: go.nih.gov/oCKKSoI

Congratulations to the newly appointed ASCO Committee leaders!
NiharikaDixit, Health Policy Committee
Sam Brondfield, MD, MAEd, Education Council
Dr. Jo Chien, AM Scientific Program Committee
Joshua Reuss, Membership Advisory Committee
Steve Lee, Coverage & Reimbursement Steering Group

If you’re in the DMV area, the lovely Dr. Michael Conroy and I will be discussing updates in #NSCLC on May 16th! RSVP using the following link: cancersupportcommunity.salsalabs.org/lung-cancer-sy… . The fabulous thoracic experts, Drs. Susan Combs Scott, MD and Joshua Reuss, will be in attendance as well! #lcsm

Inaugural African American Lung Cancer Patient & Caregiver Summit is around the corner. Hope you can join us! #HCLungCancerSummit #healcollaborative

Thanks to IDEOlogy Health and chairs Drs. Tina Cascone and Stephen V Liu, MD for organizing another successful #TexasLung24 ! It was a privilege to attend! TLC Conference IASLC #lcsm

Never underestimate the power of your story. It is the fuel for change. Founders Heidi Nafman-Onda & pierre onda continue to share & welcome all stories to join so we can all #keepgoing . We thank Xavier & Chelsea for telling their story early in their journey
#ItsUp2Us #TexasLung24

Thank you Heidi Nafman-Onda for sharing your story and for all that you do for the #lung #cancer community! The White Ribbon Project™ TLC Conference #TexasLung24 IASLC Georgetown Hematology/Oncology Fellowship #lcsm

I am so lucky to work with our dedicated and talented second-year fellow, Dr. Vanya Aggarwal!

So proud of her achievements.

Georgetown Lombardi

Expert presentation at #TexasLung24 on thymic malignancies from Dr. Chul Kim - while rare, there have been important data on novel systemic approaches. Looking forward to results from the ongoing sacituzumab govitecan study led by Drs. Kim and Jennifer Marks, MD

Chillingly powerful opening of #TexasLung24 and important reminder of why we are all in this fight together! TLC Conference